Bromocriptine treatment in a Murine Parkinson's model: Ultrastructural evaluation after dopaminergic deafferentation

International Journal of Neuroscience

Volumn 115, Issue 6, 2005, Pages 851-859

  Avila Costa, María Rosa ^a,b   Colín Barenque, Laura ^a   Montiel Flores, Enrique ^a   Aley Medina, Patricia ^a   Gutiérrez Valdez, Ana Luisa ^a   Ordóñez Librado, José Luis ^a   Flores Martínez, Erick ^a   Anaya Martínez, Verónica ^a   Mussali Galante, Patricia ^b   Fortoul, Teresa I ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antioxidants; Bromocriptine; Caudate nucleus; Neuroprotection; Oxidative stress; Parkinson's disease; Ultrastructure

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEAFFERENTATION; DOPAMINERGIC SYSTEM; ELECTRON MICROSCOPY; MALE; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; RAT; ROTATION; SUBSTANTIA NIGRA; SYNAPSE; TREATMENT OUTCOME;

ANIMALS; ANTIPARKINSON AGENTS; BROMOCRIPTINE; CAUDATE NUCLEUS; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MOTOR ENDPLATE; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RATS, WISTAR;

EID: 20044393063     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450590897059     Document Type: Article

References (17)

1. Adams, J. D., & Odzune, I. N. (1991). Oxygen free radicals and Parkinson's disease. Free Radical Biology and Medicine, 10, 161-169.
2. Avila-Costa, M. R., Colín-Barenque, L., Espinosa-Villanueva, J., & Machado-Salas, J. (1998). Degeneración del neuropilo del núcleo caudado en la enfermedad de Parkinson y en el modelo experimental provocado con 6-OHDA: Análisis ultraestructural comparativo. Patología, 36, 297-301.
3. Cohen, G. (1984). Oxy-radical toxicity in chatecolamine neurons. Neurotoxicology, 5, 77-82.
4. Forno, L. S., & Norville, R. L. (1979). Ultrastructure of the neostriatum Huntington's and Parkinson's disease. Advances in Neurology, 23, 123-135.
5. Hornykiewicz, O., & Kish S. J. (1986). Biochemical pathophysiology of Parkinson's disease. Advances in Neurology, 45, 19-34.
6. Ingham, C. A., Hood, S. H., & Arbuthnott, G. W. (1991). A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway. Neuroscience, 42, 715-730.
7. Machado-Salas, J. P., Ibarra, O., Martínez-Fong, D., Cornejo, A., Aceves, J., & Kuri, J. (1989). Degenerative ultrastructural changes observed in the neuropil of caudate nuclei from Parkinson's disease patients. Stereotactic Functional Neurosurgery, 54/55, 297-305.
8. Marsden, C. D., & Parkes, J. D. (1976). "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet, 1, 292-296.
9. McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988). Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Research, 455, 148-152.
10. Ogawa, N., Tanaka, K., Asanuma, M., Kawai, M., Masumizu, T., Kohno, M., & Mori, A. (1994). Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Research, 657, 207-213.
11. Paxinos, G., & Watson, C. (1986). The rat brain in Stereotaxic Coordinates (2nd ed.). New York: Academic Press.
12. Pickel, V. M., Johnson, E., Carson, M., & Chan, J. (1992). Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxidopamine. Developmental Brain Research, 70, 75-86.
13. Roberts, R., & DiFiglia, M. (1990). Evidence for synaptic proliferation, reorganization, and growth in the exitotoxic lesioned adult rat caudate nucleus. Experimental Neurology, 107, 1-10.
14. Sawada, H., Masakazu, I., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., & Shimohama, S. (1998). Dopamine D2-type agonists protect mescencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Annals of Neurology, 44, 110-119.
15. Ungerstedt, U. (1968). 6-Hydroxydopamine induced degeneration of central monoaminergic neurons. European Journal of Pharmacology, 5, 107-110.
16. Ungerstedt, U., & Arbuthnott, G. W. (1970). Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Research, 24, 485-493.
17. Yoshikawa, T., Minamiyama, Y., Naito, Y., & Kondo, M. (1994). Antioxidant properties of bromocriptine, a dopamine agonist. Journal of Neurochemistry, 62, 1034-1038.